Literature DB >> 34891154

Tumor immune microenvironment lncRNAs.

Eun-Gyeong Park1, Sung-Jin Pyo1, Youxi Cui1, Sang-Ho Yoon1, Jin-Wu Nam1,2,3.   

Abstract

Long non-coding ribonucleic acids (RNAs) (lncRNAs) are key players in tumorigenesis and immune responses. The nature of their cell type-specific gene expression and other functional evidence support the idea that lncRNAs have distinct cellular functions in the tumor immune microenvironment (TIME). To date, the majority of lncRNA studies have heavily relied on bulk RNA-sequencing data in which various cell types contribute to an averaged signal, limiting the discovery of cell type-specific lncRNA functions. Single-cell RNA-sequencing (scRNA-seq) is a potential solution for tackling this limitation despite the lack of annotations for low abundance yet cell type-specific lncRNAs. Hence, updated annotations and further understanding of the cellular expression of lncRNAs will be necessary for characterizing cell type-specific functions of lncRNA genes in the TIME. In this review, we discuss lncRNAs that are specifically expressed in tumor and immune cells, summarize the regulatory functions of the lncRNAs at the cell type level and highlight how a scRNA-seq approach can help to study the cell type-specific functions of TIME lncRNAs.
© The Author(s) 2021. Published by Oxford University Press.

Entities:  

Keywords:  bulk RNA-sequencing; cell type-specific expression; immune cells; long non-coding RNA; single-cell RNA-sequencing; tumor immune microenvironment

Mesh:

Substances:

Year:  2022        PMID: 34891154      PMCID: PMC8769899          DOI: 10.1093/bib/bbab504

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  274 in total

Review 1.  The emergence of lncRNAs in cancer biology.

Authors:  John R Prensner; Arul M Chinnaiyan
Journal:  Cancer Discov       Date:  2011-10       Impact factor: 39.397

2.  LincRNA-p21 knockdown reversed tumor-associated macrophages function by promoting MDM2 to antagonize* p53 activation and alleviate breast cancer development.

Authors:  Lining Zhou; Yu Tian; Fang Guo; Bin Yu; Jiali Li; Huaxi Xu; Zhaoliang Su
Journal:  Cancer Immunol Immunother       Date:  2020-02-15       Impact factor: 6.968

3.  Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy.

Authors:  Kenji Takahashi; Irene K Yan; Joseph Wood; Hiroaki Haga; Tushar Patel
Journal:  Mol Cancer Res       Date:  2014-05-29       Impact factor: 5.852

4.  A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth.

Authors:  Jin-Zhou Huang; Min Chen; Xing-Cheng Gao; Song Zhu; Hongyang Huang; Min Hu; Huifang Zhu; Guang-Rong Yan
Journal:  Mol Cell       Date:  2017-10-05       Impact factor: 17.970

5.  Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma.

Authors:  Aparna Bhaduri; Elizabeth Di Lullo; Diane Jung; Sören Müller; Elizabeth Erin Crouch; Carmen Sandoval Espinosa; Tomoko Ozawa; Beatriz Alvarado; Julien Spatazza; Cathryn René Cadwell; Grace Wilkins; Dmitry Velmeshev; Siyuan John Liu; Martina Malatesta; Madeline Gail Andrews; Mohammed Andres Mostajo-Radji; Eric Jinsheng Huang; Tomasz Jan Nowakowski; Daniel Amos Lim; Aaron Diaz; David Ronan Raleigh; Arnold Richard Kriegstein
Journal:  Cell Stem Cell       Date:  2020-01-02       Impact factor: 24.633

6.  p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes.

Authors:  Michal Krawczyk; Beverly M Emerson
Journal:  Elife       Date:  2014-04-29       Impact factor: 8.140

7.  LncRNA loc285194 is a p53-regulated tumor suppressor.

Authors:  Qian Liu; Jianguo Huang; Nanjiang Zhou; Ziqiang Zhang; Ali Zhang; Zhaohui Lu; Fangting Wu; Yin-Yuan Mo
Journal:  Nucleic Acids Res       Date:  2013-04-04       Impact factor: 16.971

Review 8.  Pan-cancer analysis of long non-coding RNA NEAT1 in various cancers.

Authors:  Shufen Li; Jingming Li; Chen Chen; Rongsheng Zhang; Kankan Wang
Journal:  Genes Dis       Date:  2017-11-21

9.  Long non-coding RNA MIAT promotes papillary thyroid cancer progression through upregulating LASP1.

Authors:  Wei Liu; Zhenglin Wang; Cong Wang; Zhilong Ai
Journal:  Cancer Cell Int       Date:  2019-07-25       Impact factor: 5.722

View more
  4 in total

1.  Exosome-Derived Non-Coding RNAs in the Tumor Microenvironment of Colorectal Cancer: Possible Functions, Mechanisms and Clinical Applications.

Authors:  Xian Chen; Mengmeng Jia; Jing Ji; Zhiying Zhao; Yanjie Zhao
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

Review 2.  Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma.

Authors:  José A Peña-Flores; Mercedes Bermúdez; Rosalío Ramos-Payán; Carlos E Villegas-Mercado; Uriel Soto-Barreras; Daniela Muela-Campos; Alexis Álvarez-Ramírez; Brenda Pérez-Aguirre; Ana D Larrinua-Pacheco; César López-Camarillo; Jorge A López-Gutiérrez; Julio Garnica-Palazuelos; Marvin E Estrada-Macías; Juan L Cota-Quintero; Andrés A Barraza-Gómez
Journal:  Front Oncol       Date:  2022-08-01       Impact factor: 5.738

3.  Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients.

Authors:  Jie Wu; Dingli Song; Guang Zhao; Sisi Chen; Hong Ren; Boxiang Zhang
Journal:  Front Genet       Date:  2022-09-15       Impact factor: 4.772

4.  Comprehensive analysis of somatic mutator-derived and immune infiltrates related lncRNA signatures of genome instability reveals potential prognostic biomarkers involved in non-small cell lung cancer.

Authors:  Cai-Zhi Yang; Ting Yang; Xue-Ting Liu; Can-Feng He; Wei Guo; Shan Liu; Xiao-Hui Yao; Xi Xiao; Wei-Ran Zeng; Li-Zhu Lin; Zhong-Yu Huang
Journal:  Front Genet       Date:  2022-09-26       Impact factor: 4.772

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.